Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 25, 2024

BUY
$235.51 - $267.98 $206,777 - $235,286
878 New
878 $219,000
Q4 2023

Feb 14, 2024

BUY
$185.1 - $233.13 $25,728 - $32,405
139 New
139 $32,000
Q2 2022

Aug 09, 2022

SELL
$237.11 - $299.66 $1.17 Million - $1.48 Million
-4,946 Closed
0 $0
Q1 2022

May 10, 2022

BUY
$257.27 - $315.76 $1.27 Million - $1.56 Million
4,946 New
4,946 $1.45 Million
Q4 2020

Feb 05, 2021

SELL
$212.5 - $245.46 $850 - $981
-4 Closed
0 $0
Q3 2020

Nov 12, 2020

SELL
$177.16 - $215.33 $12,932 - $15,719
-73 Reduced 94.81%
4 $1,000
Q2 2020

Aug 10, 2020

SELL
$128.7 - $176.83 $196,138 - $269,488
-1,524 Reduced 95.19%
77 $14,000
Q1 2020

May 12, 2020

BUY
$121.39 - $169.05 $185,241 - $257,970
1,526 Added 2034.67%
1,601 $222,000
Q4 2019

Feb 06, 2020

SELL
$133.47 - $153.48 $1.76 Million - $2.03 Million
-13,217 Reduced 99.44%
75 $12,000
Q3 2019

Nov 06, 2019

BUY
$135.4 - $146.47 $1.66 Million - $1.8 Million
12,284 Added 1218.65%
13,292 $1.92 Million
Q2 2019

Aug 08, 2019

SELL
$124.88 - $143.73 $2.15 Million - $2.47 Million
-17,190 Reduced 94.46%
1,008 $144,000
Q1 2019

May 08, 2019

BUY
$97.62 - $132.29 $1.59 Million - $2.16 Million
16,300 Added 858.8%
18,198 $2.4 Million
Q4 2018

Feb 07, 2019

SELL
$94.85 - $109.54 $1.97 Million - $2.28 Million
-20,816 Reduced 91.64%
1,898 $195,000
Q3 2018

Nov 08, 2018

BUY
$98.13 - $108.9 $2.23 Million - $2.47 Million
22,677 Added 61289.19%
22,714 $2.47 Million
Q2 2018

Aug 07, 2018

SELL
$96.1 - $103.24 $12,108 - $13,008
-126 Reduced 77.3%
37 $4,000
Q1 2018

May 18, 2018

SELL
$92.16 - $103.8 $77,137 - $86,880
-837 Reduced 83.7%
163 $16,000
Q4 2017

Feb 08, 2018

SELL
$85.26 - $94.62 $8,526 - $9,462
-100 Reduced 9.09%
1,000 $93,000
Q3 2017

Nov 08, 2017

BUY
$79.29 - $88.45 $87,219 - $97,295
1,100
1,100 $94,000

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $171B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Rational Advisors LLC Portfolio

Follow Rational Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rational Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rational Advisors LLC with notifications on news.